Fred Alger Management’s Iovance Biotherapeutics IOVA Stock Holding History

Fred Alger Management’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-182,765	Closed	-$2.71M	–	452
2024 Q1	$2.71M	Buy	+182,765	New	+$2.13M	0.01%	319
2021 Q1	–	Sell	-18,822	Closed	-$873K	–	495
2020 Q4	$873K	Sell	18,822 -12,485	-40%	-$496K	﹤0.01%	378
2020 Q3	$1.03M	Sell	31,307 -36,295	-54%	-$1.11M	﹤0.01%	343
2020 Q2	$1.86M	Buy	67,602 +44,602	+194%	+$1.47M	0.01%	311
2020 Q1	$689K	Sell	23,000 -22,000	-49%	-$583K	﹤0.01%	343
2019 Q4	$1.25M	Sell	45,000 -43,000	-49%	-$978K	﹤0.01%	323
2019 Q3	$1.6M	Sell	88,000 -17,000	-16%	-$376K	0.01%	295
2019 Q2	$2.58M	Buy	105,000 +10,000	+11%	+$151K	0.01%	283
2019 Q1	$903K	Buy	+95,000	New	+$923K	﹤0.01%	340
2018 Q3	–	Sell	-8,000	Closed	-$102K	–	561
2018 Q2	$102K	Buy	+8,000	New	+$117K	﹤0.01%	392

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Fred Alger Management's IOVA Position: Q2 2024 in Review

Fred Alger Management sold out of Iovance Biotherapeutics (IOVA) in Q2 2024, closing a stake of 182,765 shares — an estimated $2.71M sold.

Fred Alger Management first reported a position in IOVA in Q2 2018 and held it in 10 quarters. The position peaked at $2.71M in Q1 2024. 295 funds tracked by Wall St. Rank hold IOVA as of Q2 2024.

Fred Alger Management reported no remaining Iovance Biotherapeutics position as of Q2 2024 after selling out during the quarter.
Fred Alger Management sold 182,765 Iovance Biotherapeutics shares in Q2 2024, an estimated $2.71M.
Fred Alger Management first reported a position in Iovance Biotherapeutics in Q2 2018 and held it in 10 quarters.
Fred Alger Management's Iovance Biotherapeutics position peaked at $2.71M in Q1 2024.
295 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2024.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.